PET and SPECT Functional Imaging Studies in Parkinsonian Syndromes: from the Lesion to Its Consequences
Overview
Affiliations
Functional imaging techniques provide major insights into understanding the pathophysiology, progression, complications, and differential diagnosis of Parkinson's disease (PD). The dopaminergic system has been particularly studied allowing now early, presymptomatic diagnoses, which is of interest for future neuroprotective strategies. The existence of a compensatory hyperactivity of dopa-decarboxylase at disease onset has been recently demonstrated in the nigrostriatal and also extrastriatal dopaminergic pathways. Modification of dopamine receptors expression is observed during PD, but the respective contribution of dopaminergic drugs and the disease process towards these changes is still debated. Abnormalities of cerebral activation are seen and are clearly task-dependent, but the coexistence of hypoactivation in some areas and hyperactivation in others is also now well established. Such hyperactivation may be compensatory but could also reflect an inability to select appropriate motor circuits and inhibit inappropriate ones by PD patients. Interestingly, dopaminergic medications or surgical therapy reverse such abnormalities of brain activation.
Bereitschaftspotential in Multiple System Atrophy.
Yang Y, Chang F, Chen J, Tsai C, Lin F, Lu M Front Neurol. 2021; 12:608322.
PMID: 34149586 PMC: 8206531. DOI: 10.3389/fneur.2021.608322.
Use of transcranial magnetic stimulation in the treatment of selected movement disorders.
Brown K, Neva J, Ledwell N, Boyd L Degener Neurol Neuromuscul Dis. 2020; 4:133-151.
PMID: 32669907 PMC: 7337234. DOI: 10.2147/DNND.S70079.
Morbelli S, Esposito G, Arbizu J, Barthel H, Boellaard R, Bohnen N Eur J Nucl Med Mol Imaging. 2020; 47(8):1885-1912.
PMID: 32388612 PMC: 7300075. DOI: 10.1007/s00259-020-04817-8.
Radiolabeled Dendrimers for Nuclear Medicine Applications.
Zhao L, Zhu M, Li Y, Xing Y, Zhao J Molecules. 2017; 22(9).
PMID: 28841180 PMC: 6151832. DOI: 10.3390/molecules22091350.
Effects of More-Affected vs. Less-Affected Motor Cortex tDCS in Parkinson's Disease.
Cosentino G, Valentino F, Todisco M, Alfonsi E, Davi R, Savettieri G Front Hum Neurosci. 2017; 11:309.
PMID: 28659778 PMC: 5466958. DOI: 10.3389/fnhum.2017.00309.